0001127602-22-006288.txt : 20220223 0001127602-22-006288.hdr.sgml : 20220223 20220223162509 ACCESSION NUMBER: 0001127602-22-006288 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20220221 FILED AS OF DATE: 20220223 DATE AS OF CHANGE: 20220223 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Finke Daniel P CENTRAL INDEX KEY: 0001844305 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-01011 FILM NUMBER: 22664094 MAIL ADDRESS: STREET 1: ONE CVS DRIVE CITY: WOONSOCKET STATE: RI ZIP: 02895 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: CVS HEALTH Corp CENTRAL INDEX KEY: 0000064803 STANDARD INDUSTRIAL CLASSIFICATION: RETAIL-DRUG STORES AND PROPRIETARY STORES [5912] IRS NUMBER: 050494040 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: ONE CVS DR. CITY: WOONSOCKET STATE: RI ZIP: 02895 BUSINESS PHONE: 4017651500 MAIL ADDRESS: STREET 1: ONE CVS DR. CITY: WOONSOCKET STATE: RI ZIP: 02895 FORMER COMPANY: FORMER CONFORMED NAME: CVS CAREMARK CORP DATE OF NAME CHANGE: 20070509 FORMER COMPANY: FORMER CONFORMED NAME: CVS/CAREMARK CORP DATE OF NAME CHANGE: 20070322 FORMER COMPANY: FORMER CONFORMED NAME: CVS CORP DATE OF NAME CHANGE: 19970128 4 1 form4.xml PRIMARY DOCUMENT X0306 4 2022-02-21 0000064803 CVS HEALTH Corp CVS 0001844305 Finke Daniel P ONE CVS DRIVE WOONSOCKET RI 02895 1 EVP/Pres, Health Care Benefits Common Stock 2022-02-21 4 A 0 34387 0 A 57713.9607 D Common Stock (pep) 3097.8084 D Common Stock (restricted) 25701 D Stock Option 54.19 2020-04-01 2029-04-01 Common Stock 32322 32322 D Stock Option 58.34 2021-04-01 2030-04-01 Common Stock 54332 54332 D Stock Option 74.30 2022-04-01 2031-04-01 Common Stock 82066 82066 D Stock Option 52.37 2022-05-31 2029-05-31 Common Stock 28640 28640 D Represents shares earned by the reporting person pursuant to certain performance stock units (the "PSUs"), which were granted to the reporting person under the Issuer's Aetna Inc. 2010 Incentive Compensation Plan (the "Aetna Plan") on June 5, 2019. The PSUs were earned based on the attainment of certain performance metrics, which performance metrics were certified by the Management and Planning Committee of the Board of Directors of the Issuer on February 21, 2022. Option became exercisable in four equal annual installments, beginning on 4/1/2020. Option became exercisable in four equal annual installments, commencing 4/1/2021. Option becomes exercisable in four equal installments, commencing 4/1/2022. Option becomes exercisable in three equal installments, commencing 5/31/2022. /s/ Daniel P. Finke 2022-02-23